These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30803841)

  • 1. Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
    Krogsgaard LW; Bech BH; Plana-Ripoll O; Thomsen RW; Rytter D
    Vaccine; 2019 Mar; 37(13):1763-1768. PubMed ID: 30803841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis.
    Krogsgaard LW; Petersen I; Plana-Ripoll O; Bech BH; Lützen TH; Thomsen RW; Rytter D
    PLoS Med; 2021 Sep; 18(9):e1003768. PubMed ID: 34495975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.
    Krogsgaard LW; Helmuth IG; Bech BH; Plana-Ripoll O; Lützen TH; Vestergaard HT; Bjerre KD; Thomsen RW; Mølbak K; Rytter D
    Vaccine; 2020 Jul; 38(35):5678-5684. PubMed ID: 32624249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    Mølbak K; Hansen ND; Valentiner-Branth P
    PLoS One; 2016; 11(9):e0162520. PubMed ID: 27611088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
    Melgaard A; Krogsgaard LW; Lützen TH; Plana-Ripoll O; Bech BH; Hansen LK; Rask CU; Rytter D
    Vaccine; 2021 Oct; 39(43):6364-6369. PubMed ID: 34561141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.
    Krogsgaard LW; Vestergaard CH; Plana-Ripoll O; Lützen TH; Vestergaard M; Fenger-Grøn M; Bech BH; Rytter D
    PLoS One; 2017; 12(9):e0184658. PubMed ID: 28886180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Ulendorf Jacobsen S; Valentiner-Branth P; Mølbak K
    Vaccine; 2018 Oct; 36(41):6158-6162. PubMed ID: 30201304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: a register-based, matched case-control study.
    Lützen TH; Bech BH; Mehlsen J; Høstrup Vestergaard C; Krogsgaard LW; Olsen J; Vestergaard M; Plana-Ripoll O; Rytter D
    Clin Epidemiol; 2017; 9():465-473. PubMed ID: 28979164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Schartau S; Heering Holt D; Lützen T; Rytter D; Mølbak K
    Vaccine; 2019 May; 37(19):2580-2585. PubMed ID: 30967312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada.
    Kliewer EV; Mahmud SM; Demers AA; Lambert P
    Vaccine; 2013 Dec; 32(1):33-8. PubMed ID: 24211170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
    Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P
    Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
    Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
    J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
    Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
    J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral HPV prevalence and HPV vaccination among special needs population in the US.
    Chandrupatla SG; Khalid I; Tavares M
    Papillomavirus Res; 2019 Dec; 8():100182. PubMed ID: 31473308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study.
    Paraskevaidis E; Athanasiou A; Paraskevaidi M; Bilirakis E; Galazios G; Kontomanolis E; Dinas K; Loufopoulos A; Nasioutziki M; Kalogiannidis I; Athanasiadis A; Papanikolaou A; Vatopoulou A; Grimbizis G; Tsolakidis D; Daponte A; Valasoulis G; Gritzeli S; Michail G; Adonakis G; Paschopoulos M; Tsonis O; Anaforidou ME; Batistatou A; Kyrgiou M;
    In Vivo; 2020; 34(3):1445-1449. PubMed ID: 32354944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
    Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.